MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Tremors: Treatment"

  • 2017 International Congress

    Efficacy and safety of incobotulinumtoxinA (inco/A) for essential tremor using kinematics-guided clinical decision support: A randomized, double-blind, placebo-controlled trial

    M. Jog, J. Lee, M. Althaus, A. Scheschonka, H. Dersch, E.T. Study Team, D. Simpson (London, ON, Canada)

    Objective: To demonstrate improvement of arm tremor severity and hand function with kinematics-guided inco/A therapy Background: Botulinum neurotoxin A (BoNT-A) therapy of debilitating tremor symptoms…
  • 2017 International Congress

    Open label study of cannabidiol in Parkinson disease

    M. Leehey, Y. LIU, C. EPSTEIN, F. HART, J. BAINBRIDGE, M. COOK, S. SILLAU, Z. BAUD, H. NEWMAN (AURORA, CO, USA)

    Objective: To determine if cannabidiol (CBD) is tolerated and effective in Parkinson disease (PD) and the dosage needed for a Phase 2 randomized controlled trial.…
  • 2017 International Congress

    The occurrence of dopamine-responsive and dopamine-resistant resting tremor in Parkinson’s disease

    H. Zach, M. Dirkx, D. Roth, j. Pasman, B. Bloem, R. Helmich (Nijmegen, Netherlands)

    Objective: To investigate dopamine-responsiveness of resting tremor in Parkinson’s disease Background: Unlike the core Parkinson motor symptom, bradykinesia, resting tremor has a variable response to…
  • 2017 International Congress

    Effect of deep brain stimulation of the subthalamic nucleus on cranial tremor in Parkinson’s disease

    L. Cameron, C. Kilbane, A. Shaikh (Cleveland, OH, USA)

    Objective: To analyze the effect of deep brain stimulation (DBS) of the subthalamic nucleus (STN) on cranial tremor in Parkinson’s disease (PD). Background: STN DBS…
  • 2017 International Congress

    Action tremor control with deep brain stimulation in patients with Parkinson’s disease: Specific target associations

    K. Nozile-Firth, V. Viswanathan, K. Foote, M. Okun, A. Wagle Shukla (Gainesville, FL, USA)

    Objective: To determine the effects of deep brain stimulation (DBS) on action tremor in Parkinson’s disease (PD) and to identify if there are specific target…
  • 2016 International Congress

    Individualized botulinum toxin type A therapy of bilateral upper limb essential tremor by multi-sensor kinematic technology

    O. Samotus, H. Moradi, M. Jog (London, ON, Canada)

    Objective: To demonstrate efficacious and safe reduction in bilateral upper limb tremor severity by serial botulinum toxin type A injection parameters kinematically determined using a…
  • 2016 International Congress

    Insulin dependent diabetes and hand tremor

    S. Khachaturyan, G. Avagyan, K. Harutyunyan, A. Voskanyan, I. Gabrielyan, H. Amirjanyan, H. Manvelyan (Echmiadzin, Armenia)

    Objective: Tremor is the most common type of involuntary movement. Clinically tremor can be classified into physiological, essential, dystonic, Parkinsonian and psychogenic. Risk for hand…
  • 2016 International Congress

    Increase L-dopa dosage for rest tremor or think about the essential tremor too?

    A. Voskanyan, G. Avagyan, E. Khachatryan, K. Harutyunyan, S. Khachaturyan, H. Amirjanyan, H. Manvelyan (Yerevan, Armenia)

    Objective: A 57-year old man with hand tremor is diagnosed with Parkinson's disease (PD) and treated with high dose levodopa (L-dopa) during last 5 years,…
  • 2016 International Congress

    Incidence of waning tremor control in essential tremor patients with deep brain stimulation

    M.D. Seier, A. Hiller, C. Murchison (Portland, OR, USA)

    Objective: To determine the incidence of loss of tremor control in essential tremor (ET) patients who have undergone ventralis intermedius thalamic nucleus deep brain stimulation…
  • 2016 International Congress

    Quantification of tremor and rigidity during deep brain stimulation surgery for Parkison’s disease

    P. Poortvliet, A. Fytagoridis, T. Coyne, P. Silburn (Brisbane, Australia)

    Objective: The aim of this study is to validate practical and objective measures to assess changes in rigidity and tremor due to micro-lesion effects and…
  • « Previous Page
  • 1
  • …
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley